The potential of synthetic indolylquinoline derivatives for Aβ aggregation reduction by chemical chaperone activity

References

Page 1

	Year	Citations
Amyloid plaque core protein in Alzheimer disease and Down syndrome. Colin L. Masters, G. Simms, Nicola A. Weinman, Proceedings of the National Academy of Sciences Down SyndromeNeurodegenerative DiseasesAlzheimer's DiseaseBiochemistryScrapie Infectivity	1985	4.4K
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Dominic M. Walsh, Igor Klyubin, Julia V. Fadeeva, Nature Synaptic PlasticityAlzheimer's DiseaseMolecular NeuroscienceAmyloid β ProteinMedicine	2002	4.2K
Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis Rakez Kayed, Elizabeth Head, Jennifer L. Thompson, Science Soluble Amyloid OligomersAlzheimer's DiseaseBiochemistryProtein AssemblyProtein Folding	2003	4K
Antioxidant and radical scavenging properties of curcumin Tuba Parlak Ak, İlhami Gülçın Chemico-Biological Interactions Radical Scavenging PropertiesMedicinePhytochemicalPharmacologyPolyphenolics	2008	1.9K
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. Inge Grundke‐Iqbal, Khalid Iqbal, M Quinlan, Journal of Biological Chemistry	1986	1.8K
A possible role for π‐stacking in the self‐assembly of amyloid fibrils Ehud Gazit The FASEB Journal Protein AssemblyMolecular Self-assemblyMolecular BiologyProtein Phase SeparationAmyloid Fibril Formation	2002	1.1K
A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. K. Hensley, John M. Carney, Mark P. Mattson, Proceedings of the National Academy of Sciences Peptide ScienceBeta-amyloid AggregationRedox BiologyOxidative StressAlzheimer's Disease	1994	1.1K
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease Motomasa Tanaka, Yoko Machida, Sanyong Niu, Nature Medicine BiochemistryNatural SciencesMolecular BiologyDegenerative DiseaseHuntington Disease	2004	773
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Alex E. Roher, Jonathan D. Lowenson, Steven Clarke, Proceedings of the National Academy of Sciences PathologyVascular AmyloidAlzheimer's DiseaseMajor ComponentBioanalysis	1993	738
Molecular basis for amyloid fibril formation and stability O. Sumner Makin, E. D. T. Atkins, Pawel Sikorski, Proceedings of the National Academy of Sciences	2005	666

Page 1